| abstract |
The present invention relates to the use of genetic engineering to produce sterol esters. In one embodiment, an isolated or recombinant nucleic acid molecule encoding a sterol acyltransferase is disclosed. In another embodiment, a cell transformed with the isolated or recombinant nucleic acid molecule encoding a sterol acyltransferase is disclosed. A process for producing sterol esters using the transformed cell is also disclosed. In a further embodiment; an isolated or recombinant sterol acyltransferase is disclosed. |